News
Welcomes Vice President of Research and Development, Vice President of Marketing and Vice President of Sales to fuel innovation and growth SAN DIEGO, Calif. — April 29, 2021 — Jumpcode Genomics, a genome technology platform company focused on enabling genomic analysis, today announced the appointment of three new key hires to its growing team. Jon […]
Read MoreIn a new article from GenomeWeb, Senior Editor Christie Rizk speaks with Nicholas Schork, Ph.D., Deputy Director and Distinguished Professor of Quantitative Medicine at The Translational Genomics Research Institute, about how Jumpcode’s CRISPRclean™ technology is helping researchers build a better COVID-19 test: While COVID-19 held the world in its grip throughout much of 2020, the […]
Read MoreInvestors include Baird Capital, Arboretum Ventures and LYZZ Capital; funding will accelerate commercialization of CRISPRclean™ next-generation sequencing technology Life sciences industry veteran Frank Witney joins Jumpcode Board of Directors Jumpcode opens new headquarters in San Diego biotech business hub SAN DIEGO, Calif. – Jan. 12, 2021 – Jumpcode Genomics – a genome technology company […]
Read MoreKelsey Kaustinen details how Jumpcode’s CRISPRclean technology unites NGS and CRISPR/Cas editing in a Q&A with our Chief Scientist, Dr. Stanley Nelson, in the current issue of Drug Discovery News. Read on to hear Dr. Nelson’s perspective on how CRISPRclean can benefit life sciences and biopharma industry research. Jumpcode details how its CRISPRclean tech unites […]
Read MorePatented CRISPRclean™ Technology is a Foundational Tool that Improves the Performance of Next-Generation Sequencing and Other Molecular Workflows by Increasing Sensitivity, Reducing Costs and Enabling Novel Discovery CARLSBAD, Calif. – Sept. 17, 2020 – Jumpcode Genomics – a genome technology company founded by industry veterans in 2016 focused on improving the understanding of human disease – today exited stealth mode and […]
Read More